Cutaneous Manifestations of Diabetes Mellitus
Persistently high blood sugar in diabetes mellitus (DM) damages many organ systems, and the skin is often where that damage shows up first and most clearly. Clinical data show that about 30–70% of people with diabetes (type 1 and type 2) develop at least one skin manifestation over the course of their disease.
How diabetes damages the skin:
- Buildup of advanced glycation end-products (AGEs): Glucose binds non-enzymatically to collagen and elastin in the dermis, increasing cross-linking. The skin loses elasticity, stiffens, and repairs itself less effectively.
- Microangiopathy and peripheral neuropathy: Thickened capillary basement membranes and damaged sensory nerves reduce blood flow to the skin and reduce sweating, leading to dry, cracked skin and loss of protective sensation in the hands and feet.
- Weakened local immunity: High tissue glucose impairs neutrophil phagocytosis and chemotaxis, turning the skin into fertile ground for persistent bacterial and fungal infections.
- Hyperinsulinemia and insulin resistance: High circulating insulin directly stimulates IGF-1 (insulin-like growth factor 1) receptors on keratinocytes and fibroblasts, causing epidermal overgrowth that appears as characteristic thickened skin.
Spotting these skin signs early not only helps diagnose diabetes before it becomes obvious but is also an important indicator of small-vessel damage (kidneys, retina) and large-vessel disease. At Haute-Derma, our dermatology consultations build in a detailed metabolic screen, so we can pick up skin warning signs of diabetes early and plan safe treatment that helps prevent necrosis and poor wound healing.
Clinical Features and Skin Signs of Diabetes
Skin changes in diabetes fall into several main groups based on how they develop:
- Lesions Highly Specific to Diabetes:
- Necrobiosis lipoidica (NLD): Seen in 0.3–1% of people with diabetes (three times more often in women than men). It begins as well-defined red-brown papules on the front of the shins, which evolve into oval atrophic plaques with a shiny yellow-orange center through which twisting dilated capillaries are clearly visible. About 15–33% of NLD plaques may develop chronic, hard-to-heal or painful ulcers.
- Diabetic dermopathy (shin spots): The most common skin finding (over 50% of people with long-standing diabetes). It appears as round or oval brown atrophic patches under 1 cm, symmetrically on the front of both shins. The spots are painless and not itchy and result from microangiopathy and hemosiderin deposits.
- Diabetic blisters (bullosis diabeticorum): Tense, clear fluid-filled blisters from a few millimeters to several centimeters appear suddenly on the lower legs, feet, or hands. They have no surrounding redness, are painless, and heal on their own in 2–6 weeks without scarring.
- Scleredema diabeticorum and diabetic stiff skin: Scleredema causes thick, hard, less elastic skin on the upper back, nape, and neck. It is distinct from diabetic cheiroarthropathy, in which the skin of the hands thickens and stiffens and the fingers cannot fully straighten (the prayer sign).
- Lesions Linked to Insulin Resistance and Metabolic Disorders:
- Acanthosis nigricans (AN): Thickened, gray-brown to black, velvety plaques in skin folds (neck, armpits, groin, under the breasts). It is a direct clinical warning sign of severe insulin resistance.
- Generalized granuloma annulare: Skin-colored or pale pink papules arranged in rings that erupt in large numbers on the trunk and limbs, closely linked to poorly controlled diabetes.
- Persistent, Recurrent Skin Infections:
- Candida infections: Recurrent angular cheilitis, intertrigo of the finger webs or groin, vaginitis, and balanitis caused by Candida.
- Bacterial infections: Boils (furuncles), carbuncles (caused by Staphylococcus aureus), and cellulitis that progress quickly and can lead to deep tissue necrosis.
Distinctive Skin Lesions in People With Diabetes
| Necrobiosis Lipoidica (NLD) | Diabetic Dermopathy | Acanthosis Nigricans |
|---|---|---|
| Atrophic plaque with a yellow-orange center, red-brown border, and superficial dilated vessels | Small, dark brown atrophic patches with clear borders, flat or slightly sunken | Thickened, brown-black, velvety plaques |
| Front of the shins (85%), symmetric | Front of both shins (shin spots) | Skin folds: neck, armpits, groin, knuckles |
| Fibrin deposits, dermal collagen necrosis, vasculitis | Damaged small vessels leak red blood cells and hemosiderin | High insulin stimulates IGF-1 receptors, driving overgrowth |
| Prone to chronic ulceration (15–33%), painful when ulcerated | Completely symptom-free, does not ulcerate | Painless; mainly a cosmetic concern and a metabolic warning sign |
| Does not closely track HbA1c levels | Reflects chronic microvascular complications | Directly reflects the degree of insulin resistance |
Screening, Management, and Treatment at Haute-Derma
At Haute-Derma, every patient with skin lesions that may be related to diabetes is managed through a standardized medical pathway:
Metabolic Screening and Clinical Testing
- Metabolic markers: Patients with acanthosis nigricans, necrobiosis lipoidica, granuloma annulare, or recurrent fungal infections are tested right away for fasting plasma glucose, HbA1c, HOMA-IR insulin resistance, and a lipid panel.
- Peripheral blood flow (ABI): The ankle-brachial index (ABI) is measured in patients with atrophic patches or leg ulcers to assess atherosclerosis in the lower-limb arteries.
Treatment Principles
- No invasive cosmetic procedures when HbA1c is above 7.5%: Deep peels, aggressive fractional CO2 laser, microneedling, and mesotherapy injections are never performed in patients whose blood sugar is not well controlled. High blood sugar impairs healing and increases the risk of necrotizing infection and hypertrophic scarring.
- Do not try to strip acanthosis nigricans with strong acids: Applying strong acids to remove dark patches on the neck or armpits causes chemical burns, contact dermatitis, and worse post-inflammatory hyperpigmentation (PIH).
Combined Treatment at Haute-Derma
- Controlling the underlying cause: We work closely with endocrinologists to bring blood sugar under control (HbA1c below 7.0%). This is essential to stop skin lesions from progressing.
- Treating acanthosis nigricans: Lifestyle changes (weight loss, reducing insulin resistance) combined with a topical retinoid (tretinoin 0.05%–0.1%) or urea 10–20% to normalize keratinization.
- Treating necrobiosis lipoidica (NLD):
- Early stage (not ulcerated): a potent topical corticosteroid or intralesional corticosteroid injections (triamcinolone acetonide) at the active edge of the plaque.
- Ulcerated stage: standard wound care (wound bed preparation using the TIME framework), red/infrared LED light therapy to stimulate healing, and a calcineurin inhibitor (tacrolimus 0.1%).
- Infection control: Appropriate broad-spectrum antibiotics or antifungals guided by bacterial/fungal culture and sensitivity results.
